Stay updated on Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.

Latest updates to the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedThe study now indicates transition to a long-term extension phase (LTEP) with Part E closed to enrollment; Part D and Part F closed, and Part G enrolling only for HNSCC with its cohort not opened. Part A dosing is now listed as every 3 weeks, and Part D dosing on Day 1 of each 21-day cycle; the page reports 172 locations.SummaryDifference0.5%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a comprehensive list of trial locations across multiple states and countries, and removed several locations from the list.SummaryDifference2%

- Check41 days agoChange DetectedThe study locations list has been expanded to 174 sites across the United States and internationally, including UC San Diego, Yale-New Haven, Massachusetts General Hospital, OHSU, and Ophthalmic Consultants of Boston. The total number of locations shown is now 174.SummaryDifference0.8%

- Check56 days agoChange DetectedPubMed publications note text was updated to state that publications are automatically filled in from PubMed, a public database of scientific and medical articles, with a version update to v3.3.2.SummaryDifference0.0%

- Check63 days agoChange DetectedRemoved the general government funding operating-status notice from the page; the study details and inclusion criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check77 days agoChange DetectedThere are no significant changes between the two screenshots. The study details and listed locations appear unchanged.SummaryDifference0.2%

Stay in the know with updates to Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tisotumab Vedotin Efficacy in Solid Tumors Clinical Trial page.